Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials

by Joan B Mannick, MD, Grace Teo, PhD, Patti Bernardo, PhD, Dean Quinn, MD, Kerry Russell, MD, Lloyd Klickstein, MD, William Marshall, MD, Sarb Shergill, PhD
Published 2021-05-01